Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The lived experience of severe pain, understandably, can lead to a process of catastrophizing, which is a cognitive distortion where patients assume the worst possible outcome in any situation where ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...